News/ News/ R&D Broad, MilliporeSigma issue call to make access to CRISPR freer Phil Taylor Broad Institute, CRISPR/Cas9, gene editing, MilliporeSigma 0 Comment Gene-editing with CRISPR/Cas9 is promising a revolution in medicine, but battles over intellectual property (IP) have made it Share X Broad, MilliporeSigma issue call to make access to CRISPR freer https://pharmaphorum.com/news/broad-milliporesigma-issue-call-to-make-access-to-crispr-freer/
Broad Institute, CRISPR/Cas9, gene editing, MilliporeSigma
0 Comment
